Henry Schein Appoints Dan Daniel as Independent Chairman Following Stanley Bergman’s Retirement
Henry Schein has announced a major leadership transition as its Board of Directors elected William K. “Dan” Daniel to serve as Independent Chairman of the Board, effective May 21, 2026. Mr. Daniel succeeds Stanley M. Bergman, who retired from the Board after more than four decades of leadership and service to the company.
The announcement marks the end of an era for Henry Schein, one of the world’s largest providers of healthcare products, services, and technology solutions to office-based dental and medical practitioners. Bergman served as a Director of the company for 44 years and played a central role in shaping Henry Schein into a global healthcare solutions leader.
In recognition of his longstanding contributions, Bergman has been named Chairman Emeritus, an honorary title acknowledging his impact on the organization’s growth, culture, and strategic direction over the years.
Mr. Daniel joined Henry Schein’s Board of Directors in May 2025 and brings extensive executive leadership experience spanning the healthcare and industrial sectors. His appointment as Independent Chairman reflects the company’s focus on continuity, operational expertise, and long-term strategic expansion.
Daniel previously spent 14 years as Executive Vice President at Danaher Corporation, where he managed several business divisions, including Danaher’s dental portfolio. During his tenure, he played an important role in strengthening Danaher’s operational systems, business culture, and global growth initiatives.
He was also involved with Envista Holdings Corporation as a Board Director following its separation from Danaher as an independent public company. His experience in healthcare technology, dental markets, and global business management is expected to support Henry Schein’s ongoing strategic priorities.
Speaking about his appointment, Daniel expressed appreciation for the opportunity to lead the Board and continue the legacy built by Bergman and the company’s leadership team.
“I am deeply honored to assume the role of Chairman and am committed to building upon the extraordinary foundation that Stan Bergman and Team Schein established over his tenure,” said Daniel.
He praised Bergman’s leadership and noted that his vision and dedication helped establish Henry Schein as a leading provider of products, services, and technology platforms for healthcare professionals around the world.
Daniel also emphasized that Bergman’s contributions extended beyond business performance, highlighting the impact he made on shareholders, supplier partners, customers, employees, and broader communities served by the company.
He added that he looks forward to working closely with the Board and leadership team as Henry Schein enters what he described as an exciting new chapter of growth and innovation.
Bergman, who has been one of the most influential figures in the company’s history, reflected on his decades-long tenure with gratitude and optimism about the company’s future leadership.
“It has been an honor to lead Team Schein and serve as Chairman of the Board,” Bergman said.
He noted that he has worked alongside Daniel for many years and expressed strong confidence in his leadership capabilities, business knowledge, and strategic judgment.
Bergman added that Henry Schein is positioned for continued success under Daniel’s guidance and said he looks forward to supporting the organization in his new role as Chairman Emeritus.
During Bergman’s leadership, Henry Schein expanded significantly through acquisitions, digital transformation initiatives, and international growth. The company developed into a global provider serving healthcare professionals across dental and medical markets with products ranging from practice management technology to clinical supplies and business solutions.
Industry observers often credit Bergman with helping create Henry Schein’s strong corporate culture and long-term customer relationships while maintaining a focus on social responsibility and healthcare access initiatives.
The leadership transition also received strong support from Fred Lowery, the company’s Chief Executive Officer.
Lowery thanked Bergman for his extraordinary service and recognized the transformative impact he had on the company over more than four decades.
“On behalf of Team Schein, I want to express our profound gratitude to Stan for his remarkable contributions over more than four decades,” Lowery said.
He explained that Bergman’s leadership has positioned Henry Schein for continued expansion and long-term growth opportunities across global healthcare markets.
Lowery also welcomed Daniel as the company’s new Chairman, emphasizing that his deep understanding of healthcare markets and proven executive leadership experience will be highly valuable as Henry Schein advances its long-term business strategy.
According to Lowery, the company remains focused on building what it describes as the healthcare industry’s most trusted and comprehensive platform of integrated solutions. The strategy centers on helping practitioners improve operational efficiency while enhancing patient care quality, accessibility, and clinical outcomes.
The appointment comes at a time when healthcare providers are increasingly relying on technology-driven solutions, digital workflows, and integrated practice management systems to navigate evolving patient needs and industry demands.
Henry Schein has continued investing in digital technologies, data-driven healthcare tools, and global partnerships aimed at supporting healthcare practitioners in managing their businesses more effectively.
Daniel’s background in operational excellence and healthcare-focused business systems is expected to align closely with these priorities. His experience leading large-scale organizations and overseeing dental industry operations could help further strengthen Henry Schein’s position in the global healthcare marketplace.
The transition also highlights the company’s broader commitment to leadership continuity and strategic stability. By appointing an experienced executive with a strong background in healthcare operations and corporate governance, Henry Schein appears focused on maintaining momentum while pursuing future growth opportunities.
As the company enters this new phase, investors, employees, and healthcare partners will likely be watching closely to see how Daniel and the leadership team continue building on the foundation established during Bergman’s tenure.
With a combination of experienced leadership, expanding healthcare technology capabilities, and a global customer base, Henry Schein is positioning itself to continue playing a major role in supporting office-based healthcare professionals worldwide.
About Henry Schein, Inc.
Henry Schein, Inc. (Nasdaq: HSIC) is a products, services, and technology platforms company for healthcare customers. With more than 25,000 Team Schein Members worldwide, the Company’s network of trusted advisors provides more than 1 million customers globally with more than 300 valued solutions that help improve operational success and clinical outcomes. Our Business, Clinical, Technology and Supply Chain solutions help office-based dental and medical practitioners work more efficiently so they can provide quality care more effectively. These solutions also support dental laboratories, government and institutional health care clinics, as well as other alternate care sites.
Henry Schein operates through a centralized and automated distribution network, with a selection of more than 300,000 branded products and Henry Schein corporate brand products in our main distribution centers.
A FORTUNE 500 Company and a member of the S&P 500® index, Henry Schein is headquartered in Melville, N.Y., and has operations or affiliates in 34 countries and territories. The Company’s sales reached $13.2 billion in 2025, and have grown at a compound annual rate of approximately 11.0 percent since Henry Schein became a public company in 1995.
